Author

Rigney E Turnham

University of California, San FranciscoORCID 0009-0004-7483-6350Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Assay:proteomics· 1

Frequent Co-Authors

John Dozier GordaniD· 2 shared Aidan KeithiD· 1 shared Changliang He· 1 shared Clarise G Rivera· 1 shared Danielle L SwaneyiD· 1 shared Dominique C. MitchelliD· 1 shared Gary K.L. ChaniD· 1 shared Jin Liu· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 27 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

John Dozier GordanORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintNov 12, 2026

Overcoming resistance to KRAS inhibition in KRAS/PIK3CA co-mutated colorectal cancer

Lucille Ferret, José L Montaño, Kasturi B Nayak…·John D Gordan

This study shows that PI3K mutations contribute to resistance to KRAS inhibitors in colorectal cancer and that combining RAS and PI3K inhibition overcomes this resistance.

DOI 10.64898/2026.11.10.765758

humanproteomics

𝕏 PostBluesky

BiochemistryCell chemical biologyPeer-reviewedAug 1, 2026

Small molecule activation of the tumor suppressor kinase LKB1

Lin Song, Dominique C. Mitchell, Jin Liu…·John Dozier Gordan

This study develops small molecules that activate the tumor suppressor kinase LKB1 and shows their therapeutic benefits in cancer cell lines.

3 citations

humanexperimental assay

𝕏 PostBluesky